MabCure, Inc.
MBCI
$0.0001
$0.000.00%
OTC PK
| 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | |
|---|---|---|---|---|---|
| Revenue | 500.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 500.00K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 500.00K | -- | -- | -- | -- |
| SG&A Expenses | 834.50K | 782.80K | 758.90K | 693.90K | 592.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.21M | 1.18M | 1.18M | 1.09M | 1.03M |
| Operating Income | -708.80K | -1.18M | -1.18M | -1.09M | -1.03M |
| Income Before Tax | -12.26M | -1.32M | -1.51M | -1.33M | -1.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.26 | -1.32 | -1.51 | -1.33 | -1.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.26M | -1.32M | -1.51M | -1.33M | -1.23M |
| EBIT | -708.80K | -1.18M | -1.18M | -1.09M | -1.03M |
| EBITDA | -676.30K | -1.14M | -1.14M | -1.04M | -984.80K |
| EPS Basic | -0.19 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | -0.19 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 253.40M | 251.84M | 250.77M | 250.05M | 248.20M |
| Average Diluted Shares Outstanding | 253.40M | 251.84M | 250.77M | 250.05M | 248.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |